ReproCELL Incorporated
Notice of funds payment completion relating to the issuance of new shares under the Third-Party Allotment and the 19th stock acquisition rights under the Stock Issuance Program
Disclosure of payment completion for 2,932,000 new shares issued through a third-party allotment. Also, 29,320 stock acquisition rights allocated on the same date, with capital increase of approximately 410.48 million yen and funds raised of approximately 549.46 million yen. Allottee: CVI Investments, Inc. Exercise period from 2026-09-04 to 2030-09-03.
Key Figures
- 2,932,000 shares: Issued ordinary shares
- 140 yen: Issuance price
- 410,480,000 yen: Amount raised
- 29,320 units: Issued stock acquisition rights
- 186 yen: Exercise price
- 549,456,800 yen: Potential funding amount based on assumed number of underlying shares
AI要約
Section Heading
This release reports the completion of payment for the issuance of new shares under the Equity Program as the third third-party allotment and the payment completion for the 19th stock acquisition rights. Allottee is CVI Investments, Inc., with an issue price of 140 yen per share and issued shares totaling 2,932,000. The capital amount is 205,240,000 yen, and the capital surplus is the same amount. The stock acquisition rights total 29,320 units, with an exercise period from September 4, 2026 to September 3, 2030. The total funds raised are expected to be approximately 54.9 million yen.
Section 2 Heading
The allocation method is a third-party allotment, with the allottee being CVI Investments, Inc., announced on the same date as payment completion. The exercise price is 186 yen, and the potential number of shares is 2,932,000 (one stock acquisition right corresponds to 100 shares). The calculation basis uses the funding amount assuming no adjustment to the exercise price; actual funds raised may vary depending on future exercise status and market conditions.
ReproCELL Incorporated
Company overview · Stock price · Financial data · All IR
